- Home
- TBRG vs RGC Comparison
TBRG vs RGC Comparison
Compare TBRG & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TBRG
- RGC
- Stock Information
- Founded
- TBRG 1979
- RGC 2014
- Country
- TBRG United States
- RGC Hong Kong
- Employees
- TBRG N/A
- RGC N/A
- Industry
- TBRG
- RGC Medicinal Chemicals and Botanical Products
- Sector
- TBRG
- RGC Health Care
- Exchange
- TBRG NYSE
- RGC Nasdaq
- Market Cap
- TBRG 271.5M
- RGC 105.3M
- IPO Year
- TBRG N/A
- RGC 2021
- Fundamental
- Price
- TBRG $21.27
- RGC $4.86
- Analyst Decision
- TBRG Buy
- RGC
- Analyst Count
- TBRG 3
- RGC 0
- Target Price
- TBRG $14.67
- RGC N/A
- AVG Volume (30 Days)
- TBRG 78.7K
- RGC 8.8K
- Earning Date
- TBRG 02-27-2025
- RGC 10-25-2024
- Dividend Yield
- TBRG N/A
- RGC N/A
- EPS Growth
- TBRG N/A
- RGC N/A
- EPS
- TBRG N/A
- RGC N/A
- Revenue
- TBRG $337,674,000.00
- RGC N/A
- Revenue This Year
- TBRG $1.02
- RGC N/A
- Revenue Next Year
- TBRG $6.06
- RGC N/A
- P/E Ratio
- TBRG N/A
- RGC N/A
- Revenue Growth
- TBRG 0.26
- RGC N/A
- 52 Week Low
- TBRG $7.55
- RGC $3.03
- 52 Week High
- TBRG $21.80
- RGC $32.44
- Technical
- Relative Strength Index (RSI)
- TBRG 74.93
- RGC 44.96
- Support Level
- TBRG $20.62
- RGC $4.75
- Resistance Level
- TBRG $21.80
- RGC $5.21
- Average True Range (ATR)
- TBRG 0.72
- RGC 0.30
- MACD
- TBRG 0.08
- RGC 0.04
- Stochastic Oscillator
- TBRG 85.87
- RGC 23.87
About TBRG TRUBRIDGE INC
TruBridge Inc is a provider of healthcare solutions and services for community hospitals, clinics, and other healthcare systems. It provides services such as Electronic health records & information systems, revenue cycle management, population health, and data management, etc. The segments of the company are RCM, EHR, and Patient Engagement. The company derives maximum revenue from the RCM segment.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.